Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

TB-500 Injection Sites Best Locations: Administration Comparison

Abdominal subcutaneous (lateral to umbilicus) Adipose tissue Gradual depot release, 70–85% bioavailability 3–5 hours Systemic protocols, general tissue repair, no specific injury site Rotate quadrants every injection (4-site cycle) Anterior thigh (vastus later

This comparison does not assign a generated winner or score.

  • Abdominal subcutaneous (lateral to umbilicus)
  • Adipose tissue
  • Gradual depot release, 70–85% bioavailability
  • 3–5 hours
  • Systemic protocols, general tissue repair, no specific injury site
  • Rotate quadrants every injection (4-site cycle)
  • Anterior thigh (vastus lateralis) subcutaneous
  • Moderate absorption, similar to abdominal
  • 3–4 hours
  • Alternative to abdominal for limb-based administration
  • Alternate thighs every injection
  • Anterior thigh (vastus lateralis) intramuscular
  • Skeletal muscle
  • Rapid absorption, 85–95% bioavailability
  • 60–90 minutes
  • Lower body injuries (knee, hamstring, quadriceps)
  • Rotate within muscle group or alternate legs
  • Deltoid intramuscular
  • Upper body injuries (shoulder, rotator cuff, elbow)
  • Rotate deltoid heads (anterior/lateral/posterior)
  • Gluteal intramuscular
  • Rapid absorption, large muscle mass
  • Systemic IM protocols, large volume injections
  • Alternate sides every injection
  • Professional Assessment
  • N/A
  • Subcutaneous for systemic, IM near injury for localized repair
  • Match administration route to protocol goal. Proximity matters for targeted tissue repair
  • Structured rotation prevents lipohypertrophy and maintains absorption consistency
More references

Related material